J.Lo is back and this time she is ready for business!
' Morgan Radford at the event to kick off Hispanic Heritage month, Lopez Affleck opened up about embracing her culture and her appearance as a proud Latina woman: “This is my body.”
“When I went into these worlds, like Hollywood, where we were not represented at all, I almost felt like a unicorn,” she explained,
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cleaning Crew Finds Military Explosive in Newly Sold Mass. HomeSeveral homes on a Massachusetts street had to be evacuated Monday when a military explosive was found by a cleaning crew, authorities said. The home where the ordinance was found, on Wood Drive in Essex, had been recently sold, according to the Essex Police Department. A crew was cleaning it when the unknown ordinance was found inside. The suspicious item…
Read more »
Newly discovered protein connected to Alzheimer's disease riskA mutation in a newly discovered small protein is connected to a significant increase in the risk for Alzheimer's disease, expanding the known gene targets for the disease and presenting a new potential avenue for treatment, according to a new USC study.
Read more »
Anger as Kwasi Kwarteng is spotted laughing and talking at Queen’s funeralThe newly-minted Chancellor of the Exchequer was seen laughing and some accused him of taking a phone call during the proceedings of the Queen’s funeral at Westminster Abbey.
Read more »
'In loving memory': New photo of Queen Elizabeth II released after royals say final goodbye in private Windsor ceremonyA newly-released photo of Queen Elizabeth II has been issued by the Royal Family with a touching tribute after a private ceremony where she was buried with Prince Philip.
Read more »
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies - Journal of Biomedical ScienceThe novel coronavirus disease (COVID-19) pandemic remains a global public health crisis, presenting a broad range of challenges. To help address some of the main problems, the scientific community has designed vaccines, diagnostic tools and therapeutics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The rapid pace of technology development, especially with regard to vaccines, represents a stunning and historic scientific achievement. Nevertheless, many challenges remain to be overcome, such as improving vaccine and drug treatment efficacies for emergent mutant strains of SARS-CoV-2. Outbreaks of more infectious variants continue to diminish the utility of available vaccines and drugs. Thus, the effectiveness of vaccines and drugs against the most current variants is a primary consideration in the continual analyses of clinical data that supports updated regulatory decisions. The first two vaccines granted Emergency Use Authorizations (EUAs), BNT162b2 and mRNA-1273, still show more than 60% protection efficacy against the most widespread current SARS-CoV-2 variant, Omicron. This variant carries more than 30 mutations in the spike protein, which has largely abrogated the neutralizing effects of therapeutic antibodies. Fortunately, some neutralizing antibodies and antiviral COVID-19 drugs treatments have shown continued clinical benefits. In this review, we provide a framework for understanding the ongoing development efforts for different types of vaccines and therapeutics, including small molecule and antibody drugs. The ripple effects of newly emergent variants, including updates to vaccines and drug repurposing efforts, are summarized. In addition, we summarize the clinical trials supporting the development and distribution of vaccines, small molecule drugs, and therapeutic antibodies with broad-spectrum activity against SARS-CoV-2 strains.
Read more »